Skip to main content
Prof. Dr. Pröbstel
Prof. Dr. Pröbstel
Rita Carubia, Universitätsspital Basel

News categories: Focus

Welcoming Anne-Katrin Pröbstel to ImmunoSensation

Our Cluster is delighted to welcome Prof. Dr. Anne-Katrin Pröbstel as a new member. Joining from the University of Basel, where she established herself as a leading expert in neuroimmunology and immune-microbiota interactions, Anne-Katrin Pröbstel brings her innovative research to our thriving immunological community in Bonn.

Research Focus: Bridging the Immune System and the Central Nervous System

The work of Anne-Katrin Pröbstel explores the interaction between the immune system and the central nervous system, particularly in the context of neuroinflammatory and neurodegenerative diseases. She is also interested in decoding the complex interactions between the microbiota and the immune system. Her research explores the mechanisms by which immune cells, such as B and T lymphocytes, contribute to neuroinflammation and neuronal damage. By using advanced techniques such as single-cell sequencing, proteomics, functional immunoassays, and gnotobiotic mouse models, she aims to uncover critical biomarkers and therapeutic targets to advance precision medicine in neurology.

Bonn - A Thriving Hub for Immunology

When asked why she chose to join the Cluster of Excellence ImmunoSensation2 in Bonn, Anne-Katrin Pröbstel highlighted the unique collaborative environment of the Cluster of Excellence.

"Bonn stands out for its interdisciplinary approach to immunology, where cutting-edge research is seamlessly integrated with clinical applications paving the way for translational of basic research to clinical practice. The opportunity to work with outstanding scientists and clinicians in such a supportive and innovative environment was a key factor in my decision," she explained.

The robust research network in Bonn, including scientists from the University of Bonn, the German Center for Neurodegenerative Diseases (DZNE), and the University Hospital Bonn, provides a great foundation for the Pröbstel group to pursue and continue their thriving research.

Looking Ahead: Perspectives and Goals

As she settles into her new role in Bonn, Anne-Katrin Pröbstel is excited about the possibilities to expand her research and collaborate on pioneering projects within ImmunoSensation2.

"I am eager to contribute to ImmunoSensation’s mission of understanding the immune system’s sensory functions and its role in health and disease. This community offers the perfect platform to translate our findings into meaningful clinical advances," she shared.

We warmly welcome Anne-Katrin Pröbstel to Bonn and look forward to the innovative scientific discoveries that her work will bring to the ImmunoSensation2 community.

 

Related news

Prof. Dr. Jörg Wenzel

News categories: Focus

Welcoming Jörg Wenzel to ImmunoSensation

We are delighted to welcome Prof. Dr. Jörg Wenzel from the Center for Skin Diseases at the University Hospital Bonn to the Cluster of Excellence ImmunoSensation2. Jörg Wenzel is a dermatologist and physician-scientist with extensive expertise in inflammatory skin diseases and cutaneous immunology.
View entry
Prof. Dr. Marieta Toma

News categories: Focus

Welcoming Marieta Toma to ImmunoSensation

We are thrilled to welcome Prof. Dr. Marieta Toma Deputy Director of the Institute of Pathology at the University Hospital Bonn as a new member of the ImmunoSensation2 Cluster of Excellence. Marieta Toma is a leading expert in translational research with particular interest in establishing patient-derived models for cancer research.
View entry
Prof. Dr. Christian Bode

News categories: Focus

Welcoming Christian Bode to ImmunoSensation

We are delighted to welcome Prof. Dr. Christian Bode from the Department of Anesthesiology and Intensive Care Medicine at the University Hospital Bonn to the Cluster of Excellence ImmunoSensation2. Christian Bode is a physician-scientist whose work focuses on the intersection of immunology and critical care. His research centers around understanding the immune responses in patients undergoing major surgery, acute lung failure (ARDS), or sepsis.
View entry

Back to the news overview